How PerkinElmer Beat Expectations in Q4

PerkinElmer (NYSE: PKI) stock skyrocketed 48% in 2020 -- one of its best performances in years. The demand for COVID-19 testing was the primary factor behind that strong growth. Yet PerkinElmer hasn't received a lot of attention from investors seeking to profit from the surge in testing.

The healthcare company announced its fourth-quarter results after the market close on Tuesday. Again, COVID-19 was the big story. Here are the highlights from PerkinElmer's Q4 update. 

Image source: Getty Images.

Continue reading

Source Fool.com